Articles

Researchers have found that diabetes creates too much competition for an amino acid called L-arginine that helps blood vessels to relax.

European authorities have approved Novartis’s drug Galvus (vildagliptin), a DPP-4 inhibitor, as a new oral treatment for type 2 diabetes patients.

A patient’s global cardiovascular disease risk can be predicted accurately by an office-friendly algorithm, according to investigators.

Researchers report, that testosterone therapy lessens the gain in visceral adipose tissue and the loss of skeletal muscle in aging men who are not obese.

Middle-age adults who regularly eat a double burger, fries, and a diet soda for lunch or dinner increase their risk of incident metabolic syndrome by 25% compared with those who limit red meat to two servings a week.

Use of calcium-channel blockers, alpha-blockers or angiotensin-converting enzyme (ACE) inhibitors appears to offer no advantages in improving clinical outcomes compared with use of diuretics when treating hypertension among individuals with metabolic syndrome. Even more so for black patients.

A new study suggests that, a woman’s bra size at age 20 may predict her risk of developing Type 2 diabetes later in life, with larger cup size linked to higher rates of diabetes.

Patients ostensibly resistant to aspirin face significantly increased rates of life-threatening cardiovascular events, a meta-analysis has found.

According to a new study, the consequences of quitting exercise may be greater than previously thought. Results showed that the weight gained during an exercise hiatus can be tough to shed when exercise is resumed at a later date.

Researchers are reporting that an inexpensive anti-inflammatory drug similar to aspirin, salsalate, may prevent type 2 diabetes by lowering blood glucose 13 percent and reducing inflammation by 34 percent.